Marks Group Wealth Management Inc Decreases Holdings in Cigna Group $CI

Marks Group Wealth Management Inc decreased its holdings in shares of Cigna Group (NYSE:CI) by 48.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,662 shares of the health services provider’s stock after selling 12,826 shares during the period. Marks Group Wealth Management Inc’s holdings in Cigna Group were worth $3,760,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of CI. Beacon Financial Strategies CORP bought a new stake in shares of Cigna Group during the 4th quarter valued at $28,000. Lodestone Wealth Management LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at $32,000. Creative Financial Designs Inc. ADV grew its position in shares of Cigna Group by 147.3% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 81 shares during the period. Activest Wealth Management grew its position in shares of Cigna Group by 1,050.0% during the 4th quarter. Activest Wealth Management now owns 138 shares of the health services provider’s stock valued at $38,000 after acquiring an additional 126 shares during the period. Finally, Entrust Financial LLC bought a new stake in shares of Cigna Group during the 4th quarter valued at $42,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Up 0.1%

Shares of CI opened at $289.71 on Tuesday. The business’s 50 day moving average is $279.94 and its 200 day moving average is $277.41. The company has a market capitalization of $76.64 billion, a PE ratio of 12.28, a price-to-earnings-growth ratio of 1.12 and a beta of 0.28. Cigna Group has a 12-month low of $239.51 and a 12-month high of $338.89. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the company earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Research analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Analyst Upgrades and Downgrades

CI has been the subject of a number of recent research reports. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and cut their price objective for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. Jefferies Financial Group cut their price objective on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating for the company in a research report on Monday, April 20th. Wells Fargo & Company lifted their target price on shares of Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Sanford C. Bernstein lifted their target price on shares of Cigna Group from $358.00 to $371.00 and gave the company an “outperform” rating in a research note on Tuesday, May 5th. Finally, UBS Group lifted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.